Bristol-Myers Squibb (BMY) Tops Q1 EPS by 8c
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $67.01 +2.35%
Financial Fact:
Research and development: 1.14B
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Research and development: 1.14B
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Bristol-Myers Squibb (NYSE: BMY) reported Q1 EPS of $2.05, $0.08 better than the analyst estimate of $1.97. Revenue for the quarter came in at $11.3 billion versus the consensus estimate of $11.49 billion.
GUIDANCE:
Bristol-Myers Squibb sees FY2023 EPS of $7.95-$8.25, versus the consensus of $8.04.
For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- S&P 500 may pull back before midterms, but Citi says buy the dip
- UBS Reiterates Buy Rating on Bristol-Myers Squibb Co. (BMY)
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
